(TCAF) T. Rowe Price - Ratings and Ratios
Large, U.S., Equities, Technology, Healthcare
Description: TCAF T. Rowe Price
The T. Rowe Price Exchange-Traded Funds, Inc. (NYSE ARCA:TCAF) is an ETF that primarily invests in equity securities, with a focus on large U.S. companies. The funds investment strategy is centered around capitalizing on growth opportunities in various sectors, with a notable emphasis on information technology and healthcare.
From a portfolio composition perspective, the fund is non-diversified, which means it may have a higher concentration of assets in a smaller number of holdings. This could potentially lead to increased volatility, but also presents opportunities for significant gains if the funds investments perform well. Key performance indicators (KPIs) to monitor for this fund include its tracking error relative to its benchmark, sector allocation, and stock selection.
In terms of key metrics, the funds Assets Under Management (AUM) stand at approximately $4.99 billion, indicating a sizable presence in the market. To further evaluate the funds performance, investors may want to examine its expense ratio, Sharpe ratio, and beta relative to its benchmark. Additionally, analyzing the funds holdings turnover and average market capitalization can provide insights into its investment strategy and potential risks.
To assess the funds potential for future growth, investors can examine its relative performance during different market cycles, as well as its ability to adapt to changing market conditions. By evaluating these factors, investors can gain a more comprehensive understanding of the funds strengths and weaknesses, and make more informed investment decisions.
TCAF ETF Overview
Market Cap in USD | 5,441m |
Category | Large Blend |
TER | 0.31% |
IPO / Inception | 2023-06-14 |
TCAF ETF Ratings
Growth Rating | 77.7% |
Fundamental | - |
Dividend Rating | 48.9% |
Return 12m vs S&P 500 | -3.93% |
Analyst Rating | - |
TCAF Dividends
Dividend Yield 12m | 0.41% |
Yield on Cost 5y | 0.57% |
Annual Growth 5y | 42.91% |
Payout Consistency | 100.0% |
Payout Ratio | % |
TCAF Growth Ratios
Growth Correlation 3m | 92.6% |
Growth Correlation 12m | 52.9% |
Growth Correlation 5y | 93.1% |
CAGR 5y | 18.45% |
CAGR/Max DD 3y | 1.13 |
CAGR/Mean DD 3y | 19.24 |
Sharpe Ratio 12m | 1.06 |
Alpha | 0.00 |
Beta | 0.814 |
Volatility | 9.70% |
Current Volume | 837.8k |
Average Volume 20d | 877.7k |
Stop Loss | 35.9 (-3.2%) |
Signal | 0.05 |
What is the price of TCAF shares?
Over the past week, the price has changed by +0.57%, over one month by +0.35%, over three months by +7.73% and over the past year by +14.06%.
Is T. Rowe Price a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of TCAF is around 35.83 USD . This means that TCAF is currently overvalued and has a potential downside of -3.35%.
Is TCAF a buy, sell or hold?
What are the forecasts/targets for the TCAF price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 40.1 | 8.3% |
Last update: 2025-09-06 04:49
TCAF Fundamental Data Overview
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.0
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 5.44b USD (5.44b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 5.44b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 5.44b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(5.44b)/V(0.0) * Re(9.01%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.01% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for TCAF ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle